Research and Markets: Global Neuropathic Pain Drug Pipeline Capsule - 2012 Update

Thu Nov 22, 2012 6:47am EST

* Reuters is not responsible for the content in this press release.

Research and Markets: Global Neuropathic Pain Drug Pipeline Capsule - 2012 Update

Research and Markets (http://www.researchandmarkets.com/research/sc6d5r/global) has announced the addition of the "Global Neuropathic Pain Drug Pipeline Capsule - 2012 Update" report to their offering.

Fore Pharma's latest report 'Global Neuropathic Pain Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Neuropathic Pain market. It covers active Neuropathic Pain pipeline molecules in various stages of clinical trials, preclinical research, and drug discovery.

This report helps executives track competitors pipeline molecules. The information presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, executing in-licensing and out-licensing deals.

The report provides information on pipeline molecules by company and mechanism of action across the R&D stages. It also provides information on pipeline molecules developed in leading geographies (North America and Europe). Licensing activities are thoroughly captured in this report.

Key Topics Covered:

1. Neuropathic Pain - Disease Overview

2. Neuropathic Pain Pipeline Overview

3. Neuropathic Pain Phase 3 Clinical Trial Pipeline Insights

4. Neuropathic Pain Phase 2 Clinical Trial Pipeline Insights

5. Neuropathic Pain Phase 1 Clinical Trial Pipeline Insights

6. Neuropathic Pain Preclinical Research Pipeline Insights

7. Neuropathic Pain Discovery Stage Pipeline Insights

8. Neuropathic Pain Drug Development Activities - Geographic Landscape

8.1. Neuropathic Pain R&D Activities in North America

8.2. Neuropathic Pain R&D Activities in Europe

9. Neuropathic Pain Pipeline - Licensing Activities

Table 1. Neuropathic Pain Pipeline Molecules - Phase 3 Clinical Trial

Table 2. Neuropathic Pain Pipeline Molecules - Phase 2 Clinical Trial

Table 3. Neuropathic Pain Pipeline Molecules - Phase 1 Clinical Trial

Table 4. Neuropathic Pain Pipeline Molecules - Preclinical Research

Table 5. Neuropathic Pain Pipeline Molecules - Drug Discovery

Table 6. Neuropathic Pain R&D Activities by Geography

Table 7. Neuropathic Pain Pipeline Molecules - North America

Table 8. Neuropathic Pain Pipeline Molecules - Europe

Table 9. Neuropathic Pain Pipeline - Licensing Activities

Figure 1. Neuropathic Pain Pipeline Molecules by R&D Stage

Figure 2. Neuropathic Pain R&D Activities by Geography

For more information visit http://www.researchandmarkets.com/research/sc6d5r/global

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals